儿童期血清25-羟维生素D浓度与胰岛自身免疫及1型糖尿病风险:TRIGR巢式病例对照辅助研究
该研究在TRIGR辅助研究(Divia)中,纳入15个国家244例胰岛自身免疫病例和488例匹配对照,重复测定婴儿期和儿童期血清25OHD。结果显示,病例儿童在首次血清转换前18个月平均25OHD较低(57.7 vs 64.8 nmol/l,p=0.007);其中144例进展为1型糖尿病者,在首次血清转换前18个月(58.0 vs 65.0 nmol/l,p=0.018)和日历年龄12个月时(70.1 vs 75.9 nmol/l,p=0.031)25OHD均低于对照。结论提示出生后早期维生素D可能对1型糖尿病发展提供保护。
要点
- 胰岛自身免疫儿童在首次血清转换前18个月平均25OHD低于对照(57.7 vs 64.8 nmol/l,p=0.007)。
- 进展为1型糖尿病儿童在首次血清转换前18个月25OHD低于对照(58.0 vs 65.0 nmol/l,p=0.018)。
- 进展为1型糖尿病儿童在日历年龄12个月时25OHD低于对照(70.1 vs 75.9 nmol/l,p=0.031)。
核心结论
- 结果提示出生后早期维生素D可能对1型糖尿病的发展提供保护。
研究设计与样本
- TRIGR辅助研究(Divia)的巢式病例对照研究,血清样本来自15个国家的儿童。
- 病例儿童(n=244)定义为任一次样本中四种糖尿病相关自身抗体中至少两种阳性。
- 每例病例匹配两例对照(n=488),匹配因素为国家与出生日期(±1年)。
- 病例儿童中144例进展为1型糖尿病。
- 婴儿期和儿童期重复测定血清25OHD,并按首次血清转换年龄(转换前6、12、18个月及转换时)和日历年龄(0、6、12、18个月)进行比较。
主要发现
- 胰岛自身免疫儿童在首次血清转换年龄前18个月平均血清25OHD低于对照(57.7 vs 64.8 nmol/l,p=0.007)。
- 进展为1型糖尿病的儿童(n=144)在首次血清转换前18个月平均血清25OHD低于对照(58.0 vs 65.0 nmol/l,p=0.018)。
- 进展为1型糖尿病的儿童在日历年龄12个月时平均血清25OHD低于对照(70.1 vs 75.9 nmol/l,p=0.031)。
- 分析校正了采样月份、人类白细胞抗原基因型、母亲1型糖尿病和性别。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: Our aim was to study the association between serum 25-hydroxyvitamin D (25OHD) concentration and islet autoimmunity and type 1 diabetes in children with an increased genetic risk of type 1 diabetes. METHODS: Serum samples for 25OHD measurements were obtained in the Trial to Reduce IDDM in the Genetically at Risk (TRIGR) ancillary study (Divia) from children in 15 countries. Case children (n = 244) were defined as having positivity for at least two out of four diabetes-associated autoantibodies measured at any one sample. For each case child, two control children were selected matched for country and date of birth (±1 year) (n = 488). Of the case children, 144 developed type 1 diabetes. Serum 25OHD was measured repeatedly in infancy and childhood and was compared according to age at the first seroconversion (at 6, 12 and 18 months prior to and at seroconversion) and calendar age (0, 6, 12 and 18 months). RESULTS: In children with islet autoimmunity, mean serum 25OHD concentration was lower 18 months prior to the age of first seroconversion of the case children compared with the control children (57.7 vs 64.8 nmol/l, p = 0.007). In children with type 1 diabetes (n = 144), mean serum 25OHD concentration was lower 18 months prior to the age of the first seroconversion (58.0 vs 65.0 nmol/l, p = 0.018) and at the calendar age of 12 months (70.1 vs 75.9 nmol/l, p = 0.031) than in their control counterparts. Analyses were adjusted for month of sample collection, human leucocyte antigen genotype, maternal type 1 diabetes and sex. CONCLUSIONS/INTERPRETATION: The results suggest that early postnatal vitamin D may confer protection against the development of type 1 diabetes. TRIAL REGISTRATION: ClinicalTrials.gov NCT00179777.
引用
- Miettinen ME, Niinistö S, Erlund I, et al. Serum 25-hydroxyvitamin D concentration in childhood and risk of islet autoimmunity and type 1 diabetes: the TRIGR nested case-control ancillary study. Diabetologia. 2020. PMID: 31912198. doi:10.1007/s00125-019-05077-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。